Michel Seymour

21.0k citations
239 papers · 12.5k indexed · 6 hit papers · h-index 44
Topics
Colorectal Cancer Treatments and Studies (126 papers)Gastric Cancer Management and Outcomes (52 papers)Cancer Treatment and Pharmacology (37 papers)
Journals
The LancetJournal of Clinical OncologySHILAP Revista de lepidopterología

In The Last Decade

Michel Seymour

221 papers receiving 12.1k citations

Hit Papers

Leucovorin and Fluorouracil With or Without Oxaliplatin a...20002026200820172000201420142011201610002.0k3.0k

Peers

Michel Seymour
Comparison fields: 5 of 164
  • Oncology 9.1k
  • Pulmonary and Respiratory Medicine 3.6k
  • Surgery 3.1k
  • Pathology and Forensic Medicine 2.8k
  • Hepatology 1.9k
Replace Christophe Tournigand with:
Christophe Tournigand France
V.E.P.P. Lemmens Netherlands
Aimery de Gramont France
Roberto Labianca Italy
Axel Grothey United States
Franck Bonnetain France
Richard L. Schilsky United States
Jean Faivre France
Miriam Koopman Netherlands
Marwan Fakih United States
Michel Seymour relative to Christophe Tournigand France Christophe Tournigand's profile →
Citations per field
00.5×1.5×2.2×
Christophe Tournigand · 1×
Citations per year

Countries citing papers authored by Michel Seymour

Since Specialization
Citations

This map shows the geographic impact of Michel Seymour's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michel Seymour with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michel Seymour more than expected).

Fields of papers citing papers by Michel Seymour

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michel Seymour. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michel Seymour. The network helps show where Michel Seymour may publish in the future.

Co-authorship network of co-authors of Michel Seymour

This figure shows the co-authorship network connecting the top 25 collaborators of Michel Seymour. A scholar is included among the top collaborators of Michel Seymour based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michel Seymour. Michel Seymour is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2
Preoperative Chemotherapy for Operable Colon Cancer: Mature Results of an International Randomized Controlled Trialbreakdown →
181
3 5
4 6
5 16
6
Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studiesbreakdown →
534
7
Une idée de l'université : propositions d'un professeur militant
0
8
PROGNOSTIC VALUE OF EARLY OBJECTIVE TUMOR RESPONSE (EOTR) TO FIRST LINE SYSTEMIC THERAPY IN METASTATIC COLORECTAL CANCER (MCRC): INDIVIDUAL PATIENT DATA (IPD) META-ANALYSIS OF RANDOMIZED TRIALS FROM THE ARCAD DATABASE
2
9
Value of Mismatch Repair, KRAS , and BRAF Mutations in Predicting Recurrence and Benefits From Chemotherapy in Colorectal Cancerbreakdown →
505
10
ADDITION OF CETUXIMAB TO OXALIPLATIN-BASED COMBINATION CHEMOTHERAPY (CT) IN PATIENTS WITH K-ras WILD-TYPE ADVANCED COLORECTAL CANCER (ACRC): EFFECTS ON OVERALL SURVIVAL. MRC COIN (CR10) TRIAL RESULTS
1
11
De la tolérance à la reconnaissance : une théorie libérale des droits collectifs
2
12 6
13 0
14
La Nation Quebecoise et la Minorite Nationale Canadienne-Francaise
1
15 23
16
Excess treatment related deaths and impaired quality of life show raltitrexed is inferior to infusional 5FU regimens in the palliative chemotherapy of advanced colorectal cancer (CRC): Final results of MRC CR06
17
17
Leucovorin and Fluorouracil With or Without Oxaliplatin as First-Line Treatment in Advanced Colorectal Cancerbreakdown →
3040
18
Phase II study of irinotecan and high dose infusional 5- fluorouracil (5-FU) and folinic acid for first and second line treatment of advanced colorectal cancer
0
19
Molecular markers and the prediction of prognosis and response to therapy in colon cancer
1
20
Preliminary results of a multicentre randomised trial comparing 3 chemotherapy regimens (De Gramont, Lokich and Raltitrexed) in metastatic colorectal cancer
41

About Michel Seymour

Michel Seymour is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 239 papers that have together received 12.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (126 papers), Gastric Cancer Management and Outcomes (52 papers) and Cancer Treatment and Pharmacology (37 papers). The work is most often cited by research in Oncology (9.1k citations), Hepatology (1.9k citations) and Geriatrics and Gerontology (768 citations). Michel Seymour has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Philip Quirke, Susan D. Richman, Aimery de Gramont, Jim Cassidy, Filippo de Braud, D. Papamichael, Tim Maughan, H. Cortés-Funes, Andrés Cervantes and N Le Bail. Their work appears in journals such as The Lancet, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026